Zhuhai Rundu Pharmaceutical 润都股份
13 significant filings since 30 May 2026: 1 on share pledge, 5 on pledge released and 4 on change of interest, and 3 other kinds. The latest, on 29 Aug 2026: 关于持股5%以上股东减持计划实施完成的公告. On 13 Jul 2026 the company said it expects net profit for the period ending 30 Jun 2026 to rise by 196.70% to 216.04% from the same period a year earlier.
自 30 May 2026 起有 13 份重大公告：share pledge 1 份、pledge released 5 份、change of interest 4 份，另有 3 类。最新一份（29 Aug 2026）：关于持股5%以上股东减持计划实施完成的公告。13 Jul 2026 公司预告截至 30 Jun 2026 的净利润较上年同期上升 196.70% 至 216.04%。
| FY2026 | FY2027 | |
|---|---|---|
| Now 当前 | 0 brokers | 0 brokers |
| 7 days ago | 0 brokers | 0 brokers |
| 30 days ago | 0 brokers | 0 brokers |
| 60 days ago | 0 brokers | 0 brokers |
| 90 days ago | 0 brokers | 0 brokers |
Consensus is the median of each broker's latest forecast from the 120 days before each date. With fewer than 3 brokers, the broker count is shown. 一致预期为各券商在该日期前 120 天内最新预测的中位数；不足 3 家时显示券商数。
| FY2026 | FY2027 | |
|---|---|---|
| Last 30 days | ▲ 0 ▼ 0 = 0 | ▲ 0 ▼ 0 = 0 |
| Last 90 days | ▲ 0 ▼ 0 = 0 | ▲ 0 ▼ 0 = 0 |
Each broker's latest forecast is compared with its previous forecast for the same year. A move within 0.5% counts as unchanged. 每家券商的最新预测与其对同一年度的上一次预测比较，变动在 0.5% 以内视为不变。
A surprise needs at least 3 brokers forecasting in the 120 days before the filing. FY2025 had 0 and FY2024 had 0.